1. Figure 1 Reproductive health in patients with rheumatic diseases
Figure 1 | Reproductive health in patients with rheumatic diseases. a | Overview of the different factors that influence reproductive health in patients with rheumatic disease. b | The graph shows the number of single births in the Norwegian Medical Birth Registry during the period 1967–1995 in different groups of patients. Women with rheumatic diseases were identified according to the International Classification of Diseases (ICD8), whereas all other women formed the reference group (REF). The total number of infants in mothers with rheumatic disease was 3,325, whereas the number of infants in the reference group was 1,396,180. The rheumatic diseases were grouped into three main categories: connective tissue disease (CTD), which comprised systemic lupus erythematosus, Sjögren syndrome, systemic sclerosis and polymyositis or dermatomyositis; specified inflammatory arthritis (SA), including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis; and non-specified inflammatory arthritis (NSA). Except for women with NSA, patients with CTD and SA had a significantly lower number of children than the reference group. MTX, methotrexate; MMF, mycophenolate mofetil. This figure was adapted with permission obtained from Skomsvoll, J. F. et al. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J. Rheumatol. 28, 2310–2314 (2001).
This figure was adapted with permission obtained from Skomsvoll, J. F. et al.
Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis
of inflammatory rheumatic disease in Norwegian women. J. Rheumatol. 28, 2310–2314 (2001).
Østensen, M. (2017) Sexual and reproductive health in rheumatic disease
Nat. Rev. Rheumatol. doi: /nrrheum